Unicorn Quest – Innovators in Medical and Pharma
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
GlobalData’s Startup Series report, “Unicorn Quest – Innovators in Medical and Pharma,” highlights startups poised to become unicorns in the medical and pharma sectors. It explores how advancements such as AI-driven diagnostics, gene editing, synthetic biology, and personalized healthcare solutions help address unmet medical needs and enhance precision medicine. The report provides insights into startups’ growth potential, innovation strategies, and impact, enabling stakeholders to identify promising companies and understand their contributions to the evolving medical and pharmaceutical landscapes.
Amidst global efforts to revolutionize healthcare, startups in the medical and pharma sectors are driving transformative innovations. They are developing cutting-edge solutions in diagnostics, therapeutics, and biotechnology, including AI-powered tools, gene editing, and digital health platforms. The report Startup Series – Unicorn Quest: Innovators in Medical and Pharma highlights key startups driving healthcare innovation and disruption. Utilizing insights from GlobalData’s Disruptor Intelligence Center and expert analysis, the report provides stakeholders with a comprehensive overview of emerging trends, startup investors, and investment opportunities.
Scope
The startups featured in this report were founded in 2015 or later and provide innovative solutions in the medical and pharmaceutical sectors. Their offerings span across diagnostics, monitoring, gene editing, synthetic biology, therapeutic development, AI-driven tools, and more. Startups are leveraging technology to address critical healthcare challenges through non-invasive diagnostics, advanced gene-editing platforms, and personalized medicine.
Reasons to Buy
1. Stay updated: Gain insights into the latest advancements and potential unicorns in the medical and pharma sectors.
2. Discover new startups: The report highlights promising startups pioneering disruptive technologies in diagnostics, therapeutics, and digital tools.
3. Identify key focus areas: Understand innovation trends such as AI-driven diagnostics, gene editing, and synthetic biology, and the startups excelling in these domains.
4. Learn about innovation areas: Deep-dive into pharma and medical startups researching cutting-edge technologies to offer distinct solutions.
5. Assess investment potential: Access valuable information for assessing the investment potential of different startups.
Altamira Therapeutics
Antheia
Asimov
BioIntellisense
Closed Loop Medicine
ConcertAI
CorVista Health
Dewpoint Therapeutics
DNA Script SAS
Excision BioTherapeutics
eXo Imaging
Henlius
Hummingbird Bioscience
Karius
knowRX
MD Anderson
MedRhythms
Mission Bio
Mission Therapeutics
Mitsubishi Tanabe Pharma Corporation
MOBILion Systems
Nanite
Novo Nordisk
Obsidian Therapeutics
Palleon Pharmaceuticals
RevOpsis Therapeutics
Saliogen Therapeutics
SeLux Diagnostics
Serum Institute of India
SiPhox
Skyhawk Therapeutics
Synthekine
Tissium SA
TMRW Life Sciences
Truvian Sciences
Univercells
University of Miami
Valo Health
Visby Medical
Xilis
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals reports